TITLE

Leptin inhibits proliferation of breast cancer cells at supraphysiological concentrations by inhibiting mitogen-activated protein kinase signaling

AUTHOR(S)
WEICHHAUS, MICHAEL; BROOM, JOHN; WAHLE, KLAUS; BERMANO, GIOVANNA
PUB. DATE
July 2014
SOURCE
Oncology Letters;2014, Vol. 8 Issue 1, p374
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Leptin is a hormone secreted by white fat tissue and signals the amount of overall body fat to the hypothalamus. The circulating concentration of leptin correlates with the level of obesity. Breast cancer risk is higher in obese postmenopausal women compared with postmenopausal women of a normal weight, and high leptin concentrations may contribute to this risk. In the present study, SK-BR-3 and MDA-MB-231 breast cancer cell lines were treated with various concentrations (6.25-1,600 ng?ml) of recombinant leptin and changes in cell proliferation were assessed. The SK-BR-3 breast cancer cells exhibited a concentration-dependent increase in proliferation with physiological leptin concentrations (<100 ng?ml), but no further increase in proliferation at high leptin concentrations (>100 ng?ml) was observed. Cell proliferation was not affected at supraphysiological leptin concentrations (>800 ng?ml) in SK-BR-3 cells, whereas it decreased in MDA-MB-231 cells. Therefore, cell signaling and cell cycle changes were assessed at supraphysiological concentrations (1,600 ng?ml). In the two cell lines, leptin treatment decreased the mitogen-activated protein kinase (MAPK) cell signaling pathway activation. Leptin treatment did not increase Akt phosphorylation or significantly alter the cell population distribution across cell cycle stages. To the best of our knowledge, leptin-induced growth inhibition of breast cancer cells at supraphysiological concentrations has not been reported in the literature to date, and the findings of this study suggest that reduced MAPK activity may be the underlying cause. Thus, the effect of leptin on breast cancer growth warrants further investigation since leptin is considered to be one of the main mediators in the obesity-breast cancer connection.
ACCESSION #
110397737

 

Related Articles

  • Isorhamnetin inhibits cell proliferation and induces apoptosis in breast cancer via Akt and mitogen-activated protein kinase kinase signaling pathways. SHAN HU; LIMING HUANG; LIWEI MENG; HE SUN; WEI ZHANG; YINGCHUN XU // Molecular Medicine Reports;2015, Vol. 12 Issue 5, p6745 

    Breast cancer is the most common cause of female cancer-associated mortality. Although treatment options, including chemotherapy, radiotherapy and surgery have led to a decline in the mortality rates associated with breast cancer, drug resistance remains one of the predominant causes for poor...

  • RKTG sequesters B-Raf to the Golgi apparatus and inhibits the proliferation and tumorigenicity of human malignant melanoma cells. Fengjuan Fan; Lin Feng; Jing He; Xiao Wang; Xiaomeng Jiang; Yixuan Zhang; Zhenzhen Wang; Yan Chen // Carcinogenesis;Jun2008, Vol. 29 Issue 6, p1157 

    Raf kinase trapping to Golgi (RKTG) is a newly characterized negative regulator of the Ras–Raf–mitogen-activated and extracellular signal-regulated kinase kinase (MEK)–extracellular signal-regulated kinase (ERK)-signaling pathway via sequestrating Raf-1 to the Golgi...

  • LRP-1 Promotes Cancer Cell Invasion by Supporting ERK and Inhibiting JNK Signaling Pathways. Langlois, Benoit; Perrot, Gwenn; Schneider, Christophe; Henriet, Patrick; Emonard, Hervé; Martiny, Laurent; Dedieu, Stéphane // PLoS ONE;2010, Vol. 5 Issue 7, p1 

    Background: The low-density lipoprotein receptor-related protein-1 (LRP-1) is an endocytic receptor mediating the clearance of various extracellular molecules involved in the dissemination of cancer cells. LRP-1 thus appeared as an attractive receptor for targeting the invasive behavior of...

  • Ascorbic acid increases the activity and synthesis of tyrosinase in B16F10 cells through activation of p38 mitogen-activated protein kinase. Lee, Seung-Ah; Son, Young-Ok; Kook, Sung-Ho; Choi, Ki-Choon; Lee, Jeong-Chae // Archives of Dermatological Research;Nov2011, Vol. 303 Issue 9, p669 

    Ascorbic acid, a potential antioxidant, is known to inhibit melanogenesis. However, there are conflicting findings that ascorbic acid has very low stability and acts as a pro-oxidant, eventually increasing proliferation and melanin content in melanoma cells. In the present study, we explored the...

  • Involvement of mixed lineage kinase 3 in cancer1. Chadee, Deborah N. // Canadian Journal of Physiology & Pharmacology;Apr2013, Vol. 91 Issue 4, p268 

    Mitogen-activated protein kinase (MAPK) signaling pathways are composed of a phosphorelay signaling module where an activated MAP kinase kinase kinase (MAP3K) phosphorylates and activates a MAPK kinase (MAP2K) that in turn phosphorylates and activates a MAPK. The biological outcome of MAPK...

  • MAP kinase genes and colon and rectal cancer. Slattery, Martha L.; Lundgreen, Abbie; Wolff, Roger K. // Carcinogenesis;Dec2012, Vol. 33 Issue 12, p2398 

    Mitogen-activated protein kinase (MAPK) pathways regulate many cellular functions including cell proliferation, differentiation, migration and apoptosis. We evaluate genetic variation in the c-Jun-N-terminal kinases, p38, and extracellular regulated kinases 1/2 MAPK-signaling pathways and colon...

  • Multiple Mechanisms Mediate Resistance to Sorafenib in Urothelial Cancer. Knievel, Judith; Schulz, Wolfgang A.; Greife, Annemarie; Hader, Christiane; Lübke, Tobias; Schmitz, Ingo; Albers, Peter; Niegisch, Günter // International Journal of Molecular Sciences;2014, Vol. 15 Issue 11, p20500 

    Genetic and epigenetic changes in the mitogen activated protein kinase (MAPK) signaling render urothelial cancer a potential target for tyrosine kinase inhibitor (TKI) treatment. However, clinical trials of several TKIs failed to prove efficacy. In this context, we investigated changes in MAPK...

  • Paxillin mediates extranuclear and intranuclear signaling in prostate cancer proliferation. Sen, Aritro; De Castro, Ismary; DeFranco, Donald B.; Deng, Fang-Ming; Melamed, Jonathan; Kapur, Payel; Raj, Ganesh V.; Rossi, Randall; Hammes, Stephen R. // Journal of Clinical Investigation;Jul2012, Vol. 122 Issue 7, p2469 

    In prostate cancer, the signals that drive cell proliferation change as tumors progress from castration-sensitive (androgen-dominant) to castration-resistant states. While the mechanisms underlying this change remain uncertain, characterization of common signaling components that regulate both...

  • Starfish polysaccharides downregulate metastatic activity through the MAPK signaling pathway in MCF-7 human breast cancer cells. Lee, Kyu-Shik; Shin, Jin-Sun; Nam, Kyung-Soo // Molecular Biology Reports;Oct2013, Vol. 40 Issue 10, p5959 

    We investigated the effects of starfish ( Asterina pectinifera) polysaccharides on metastatic activity in MCF-7 estrogen receptor (ER)-positive human breast cancer cells. In wound healing assay, 12- O-tetradecanoylphorbol-13-acetate (TPA)-induced cell migration was dose-dependently decreased by...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics